12:00 AM
Apr 18, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

ImmunoGen preclinical data

In a xenograft model of follicular lymphoma, a single 10 mg/kg dose of IMGN529 led to similar tumor growth delay compared to that of twice-weekly 5 mg/kg rituximab for 3 weeks. ImmunoGen plans to...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >